<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176966</url>
  </required_header>
  <id_info>
    <org_study_id>160960</org_study_id>
    <nct_id>NCT03176966</nct_id>
  </id_info>
  <brief_title>Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis</brief_title>
  <official_title>Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator's aim is to compare the efficacy of Ropinirole (Requip) to vitamin E in the
      treatment of muscle cramps in cirrhotic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle cramps are common in liver disease, especially in patients with cirrhosis. Despite the
      association of muscle cramps with liver disease, there is a paucity of information regarding
      treatment in these patients. Many treatment options have been reported in the literature but
      no standard of treatment has been established.

      Oral vitamin E replacement has been used successfully in the management of nocturnal muscle
      cramps in cirrhotic patients. Ropinirole is primarily used for treatment of restless leg
      syndrome. An off label trial of low dose Ropinirole in clinical practice has shown some
      success in providing relief of muscle cramps in patients with cirrhosis. This study will
      compare Ropinirole to vitamin E treatment in a prospective cross-over study.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 2, 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of muscle cramps as assessed by patient survey</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Compare the incidence of muscle cramps in patients using vitamin E versus ropinirole. Patients complete a survey that assesses the frequency of muscle cramps from once weekly or less to multiple episodes per day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle cramp severity as assessed by patient survey</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Compare the severity of muscle cramps in patients using vitamin E versus ropinirole. Patients complete a survey that assesses muscle cramp pain on a scale from 0 to 5 with 0 being no pain and 5 being hurts worst.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Muscle Cramp</condition>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Vitamin E then Ropinirole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be provided with vitamin E, 400 international units (IU), at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to Ropinirole. Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropinirole then Vitamin E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be prescribed ropinirole at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to vitamin E, 400 international units (IU). Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>Patients will take 400 IU vitamin E nightly for 3 months.</description>
    <arm_group_label>Vitamin E then Ropinirole</arm_group_label>
    <arm_group_label>Ropinirole then Vitamin E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropinirole</intervention_name>
    <description>Patients will take 0.5mg ropinirole nightly for 3 months.</description>
    <arm_group_label>Vitamin E then Ropinirole</arm_group_label>
    <arm_group_label>Ropinirole then Vitamin E</arm_group_label>
    <other_name>Requip</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Muscle cramp survey</intervention_name>
    <description>Patients will complete a survey of muscle cramp frequency and severity at baseline, 3 months, and 6 months.</description>
    <arm_group_label>Vitamin E then Ropinirole</arm_group_label>
    <arm_group_label>Ropinirole then Vitamin E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients at least 18 years of age in the Vanderbilt Medical Center Hepatology Practice

          -  diagnosis of cirrhosis

          -  Self report regular muscle cramping

        Exclusion Criteria:

          -  Patients without cirrhosis

          -  Patients under the age of 18

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Porayko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>June 29, 2017</last_update_submitted>
  <last_update_submitted_qc>June 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Michael K. Porayko, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Ropinirole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

